Level C· Early human research exploring benefitsProspective StudyPubMedOpen access

Adipose-derived mesenchymal stromal cells promote an exhaustion-associated phenotype in T cells through TIM-3 upregulation independent of PD-1.

Mirshafiei S., Absalan F., Yousefi B., Shariat M., Talei AR., Baharlou R.

Prospective Study on Immune Modulation, published in Discov Oncol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Discov Oncol (2026)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
42053930
PMCID
PMC13269619
DOI
10.1007/s12672-026-05116-8

Abstract (original English)

Adipose-derived mesenchymal stromal cells (ASCs) are important components of the breast tumor microenvironment (TME) with hemostatic features and immunomodulatory abilities that can either inhibit or promote tumor growth through direct cell-cell contact or the secretion of biomolecules. This study aimed to investigate the effects of ASCs on PD-1 and/or TIM-3 expression by T cells isolated from breast tumor-draining lymph nodes (TDLNs). Lymphocytes were isolated from fresh, uninvolved axillary lymph nodes and cultured either directly with ASCs from the breast adipose tissue of healthy women (N.ASCs) or breast cancer patients (C.ASCs), or in conditioned media (CM) from these ASCs. After 48 and 72 h, the expression of PD-1 and/or TIM-3 on CD3 + , CD4 + , and CD8 + T cells was analyzed using flow cytometry. Results showed that direct co-culture with both N.ASCs and C.ASCs significantly increased the frequency of CD3 + , CD3 + CD4 + , and CD3 + CD8 + T cells expressing the exhaustion marker TIM-3 in both 48- and 72-hour cultures. This increase was independent of PD-1 expression, as both TIM-3 + PD-1 + and TIM-3 + PD-1 - T cell populations increased significantly. Interestingly, the frequency of T cell populations that expressed PD-1 without TIM-3 remained unchanged. Furthermore, culturing lymphocytes in CM of ASCs had no significant impact on the frequency of TIM-3- and/or PD-1-expr

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research